Barclays PLC 13D and 13G filings for Theravance Biopharma Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-30 3:06 pm Purchase | 2023-01-11 | 13G | THERAVANCE BIOPHARMA INC TBPH | Barclays PLC | 3,402,767 5.050% | 3,402,767 (New Position) | Filing |